我国医药制造业空间转移机制研究  

Spatial Transfer Mechanism of China's Pharmaceutical Manufacturing Industry

作　　者：夏昉 崔培旭 刘金萍 崔严尹 赫玉芳 XIA Fang;CUI Peixu;LIU Jinping;CUI Yanyin;HE Yufang(School of Health Management,Changchun University of Chinese Medicine,Changchun,Jilin,China 130117)

机构地区：[1]长春中医药大学健康管理学院,吉林长春130117

出　　处：《中国药业》2022年第8期1-5,共5页China Pharmaceuticals

基　　金：吉林省社会科学基金项目[2020B070]。

摘　　要：目的探讨我国医药制造业空间转移及其机制。方法采用偏离-份额法分析我国2006年至2016年医药制造业空间转移趋势,并运用地理探测器探讨其转移机制。结果我国医药制造业目前存在由东部地区向中西部地区转移的空间分异特征,医药制造业空间转移影响因子的影响力大小分别为劳动力要素、资本要素、技术创新、市场规模、对外开放水平。结论建议从劳动力要素、资本要素和技术创新等方面优化我国各省市医药制造业产业结构。Objective To investigate the spatial transfer and mechanism of China’s pharmaceutical manufacturing industry.Methods The spatial transfer trend of China’s pharmaceutical manufacturing industry from 2006 to 2016 was analyzed by the shift-share method,and its transfer mechanism was investigated by the geographic detector.Results China’s pharmaceutical manufacturing industry has the characteristics of spatial differentiation from the eastern region to the central and western regions currently.The impact factors of the pharmaceutical manufacturing industry’s spatial transfer are labor factors,capital factors,technological innovation,market scale,and opening-up level according to the strength of influence.Conclusion It is recommended to optimize the industrial structure of pharmaceutical manufacturing industry in provinces and cities in China in terms of labor factors,capital factors,and technological innovation.

关 键 词：医药制造业 偏离-份额法 产业转移 地理探测器 

分 类 号：R95[医药卫生—药学]